Gail M. Farfel
Net Worth

Last updated:

What is Gail M. Farfel net worth?

The estimated net worth of Dr. Gail M. Farfel is at least $6,656,880 as of 6 Sep 2025. He owns shares worth $134,681 as insider, has earned $1,486,859 from insider trading and has received compensation worth at least $5,035,340 in Zogenix, Inc. and Zogenix, Inc..

What is the salary of Gail M. Farfel?

Dr. Gail M. Farfel salary is $638,120 per year as Executive Vice President & Chief Devel. Officer in Zogenix, Inc.. He also receives $568,500 as Executive Vice President & Chief Devel. Officer in Zogenix, Inc..

How old is Gail M. Farfel?

Dr. Gail M. Farfel is 61 years old, born in 1964.

What stocks does Gail M. Farfel currently own?

As insider, Dr. Gail M. Farfel owns shares in one company:

Company Title Shares Price per share Total value
Zogenix, Inc. (ZGNX) Executive Vice President & Chief Devel. Officer 5,048 $26.68 $134,681

What does Zogenix, Inc. do?

Zogenix, Inc., a biopharmaceutical company, develops and commercializes therapies to transform the lives of patients and their families living with rare diseases in the United States. The company's lead product candidate is the Fintepla, a low-dose fenfluramine, which is in Phase III clinical trials for the treatment of seizures associated with Dravet syndrome, as well as to treat seizures associated with Lennox-Gastaut syndrome; and that is in Phase II clinical trials for the treatment of other rare epileptic syndromes and diseases. It is also developing MT1621, an investigational therapy for the treatment of a rare genetic disorder called thymidine kinase 2 deficiency. Zogenix, Inc. has a collaboration with Tevard Biosciences for the research, development and commercialization of novel gene therapies for Dravet Syndrome and other genetic epilepsies. The company was formerly known as SJ2 Therapeutics, Inc. and changed its name to Zogenix, Inc. in August 2006. Zogenix, Inc. was incorporated in 2006 and is headquartered in Emeryville, California.

ZGNX logo
ZGNX
Zogenix, Inc.
$26.68

Gail M. Farfel insider trading

Zogenix, Inc.

Dr. Gail M. Farfel has made 6 insider trades between 2018-2021, according to the Form 4 filled with the SEC.

The largest trade he's ever made was exercising 8,750 units of ZGNX stock on 25 Jun 2020. As of 6 Sep 2025 he still owns at least 5,048 units of ZGNX stock.

Transaction Date Security Shares Price per share Total value Source
Option
Common Stock 5,156 N/A N/A
Option
Common Stock 5,156 N/A N/A
Option
Restricted Stock Units 5,156 N/A N/A
Option
Restricted Stock Units 5,156 N/A N/A
Option
Restricted Stock Units 8,750 N/A N/A
Option
Common Stock 8,750 N/A N/A
Sale
Common Stock 2,573 $28.21 $72,584
Option
Common Stock 3,657 N/A N/A
Option
Common Stock 3,657 N/A N/A
Option
Restricted Stock Units 3,657 N/A N/A
Option
Restricted Stock Units 3,657 N/A N/A
Sale
Common Stock 3,446 $52 $179,192
Option
Restricted Stock Units 1,625 N/A N/A
Option
Common Stock 1,625 N/A N/A
Option
Common Stock 6,961 $13.96 $97,176
Sale
Common Stock 6,961 $43.26 $301,112
Option
Stock Option (Right to Buy) 6,961 $13.96 $97,176
Option
Stock Option (Right to Buy) 7,000 $13.96 $97,720
Option
Common Stock 7,000 $13.96 $97,720
Sale
Common Stock 7,000 $47.74 $334,166
Option
Stock Option (Right to Buy) 7,000 $13.96 $97,720
Option
Common Stock 7,000 $13.96 $97,720
Sale
Common Stock 7,000 $52.79 $369,495
Option
Stock Option (Right to Buy) 5,000 $13.96 $69,800
Option
Common Stock 5,000 $13.96 $69,800
Sale
Common Stock 5,118 $45 $230,310

Zogenix key executives

Zogenix, Inc. executives and other stock owners filed with the SEC:

  • Dr. Bradley S. Galer (63) Executive Vice President & Chief Medical Officer
  • Dr. Gail M. Farfel (61) Executive Vice President & Chief Devel. Officer
  • Dr. Stephen J. Farr (66) Co-Founder, Chief Executive Officer, Pres & Director
  • Melinda Baker Senior Director of Corporation Communications
  • Mr. Ashish M. Sagrolikar (58) Executive Vice President & Chief Commercial Officer
  • Mr. Bret E. Megargel Vice President of Corporation Devel.
  • Mr. Jeff D. Durflinger Vice President of Technical Operations & Product Supply
  • Mr. Michael P. Smith (57) Executive Vice President, Chief Financial Officer, Treasurer & Sec.
  • Mr. Stephen H. Jenner Vice President of Marketing
  • Ms. Shawnte M. Mitchell Executive Vice President, Gen. Counsel & Sec.